Biotechnology

Filter

Current filters:

None

Popular Filters

1964 to 1988 of 2301 results

Investor Icahn slams Amylin for not revealing B-MS bid

05-04-2012

Billionaire US investor Carl Icahn has sent a blistering open letter to the board of US biotech company…

AmylinBiotechnologyBristol-Myers SquibbMergers & AcquisitionsPharmaceutical

EMA tightens conflicts-of-interests policies with immediate effect

04-04-2012

The European Medicines Agency yesterday published its updated policy on conflicts of interests of the…

BiotechnologyEuropePharmaceuticalRegulation

AstraZeneca collaborates with Amgen on five MAbs

03-04-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) and Amgen (Nasdaq: AMGN), the world's largest independent…

AmgenAnti-Arthritics/RheumaticsAstraZenecaBiotechnologybrodalumabInflammatory diseasesLicensingPharmaceutical

Roche to file for trastuzumab emtansine this year, on positive Ph III results

03-04-2012

Swiss drug major Roche (ROG: SIX) says that top-line results of EMILIA, the first randomized Phase III…

BiotechnologyGenentechGlaxoSmithKlineOncologyPharmaceuticalRegulationResearchRochetrastuzumab

Government, academic and venture firms come together in March to fund translational and early-stage development

02-04-2012

A host of new initiatives focused on funding translational research and early-stage companies brought…

BiotechnologyFinancialMergers & AcquisitionsPharmaceutical

Rx&D encouraged by Canadian government innovation agenda, but has some concerns

01-04-2012

The 2012 federal budget released last week by the federal government in Canada includes initiatives to…

BiotechnologyFinancialNorth AmericaPharmaceuticalResearch

BIO supports sufficient appropriations for FDA on BsUFA and PDUFA; backed by GPhA

01-04-2012

The Biotechnology Industry Organization (BIO) has expressed its support for funding of the Food and Drug…

BiotechnologyFinancialNorth AmericaPharmaceuticalRegulation

US Supreme Court knocks back Myriad Genetics patents

01-04-2012

On Monday, March 26, the US Supreme Court sent the much-discussed Myriad Genetics patent case back to…

BiotechnologyMarkets & MarketingMyriad GeneticsNorth AmericaPatentsPrometheus LabsResearch

FDA calls for more data from Chelsea Thera on Northera

30-03-2012

The US Food and Drug Administration has issued a complete response letter regarding the New Drug Application…

BiotechnologyChelsea TherapeuticsNeurologicalNorth AmericaNortheraRegulation

Bipartisan Bill to strengthen testing of pediatric drugs launched in USA

29-03-2012

US Representative Mike Rogers (Republican, Michigan) this week introduced bipartisan legislation with…

BiotechnologyLegalNorth AmericaPharmaceuticalRegulationResearch

GSK settles with Genentech over ofatumumab patents

28-03-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has agreed a settlement with Genentech, a unit of Roche (ROG:…

ArzerraBiotechnologyGenentechGenmabGlaxoSmithKlineLegalOfatumumab InjectionOncologyPatentsPharmaceuticalRoche

Panacea Biotech inaugurates new cancer drug facility in India

28-03-2012

Indian health care management company Panacea Biotec says that it has inaugurated a new state-of-the-art…

Asia-PacificBiotechnologyFinancialMarkets & MarketingPanacea Biotec

EMA and HMA agree common approach on commercially confidential info and personal data

27-03-2012

Following recent meetings, the Heads of Medicines Agencies and the European Medicines Agency yesterday…

BiotechnologyEuropePharmaceuticalRegulationResearch

European governments must ensure R&D is converted into new businesses, new products

27-03-2012

National governments in Europe need to do more to ensure that R&D innovation in the biotech industry…

BiotechnologyEuropeFinancialRegulationResearch

Recalls threaten public confidence in vaccines and immunoglobulins

27-03-2012

Quality defects and donor tissue history must be more carefully monitored to increase public acceptance…

BiotechnologyHealthcareImmunologicalsRegulationVaccines

Pharming in deal with Hyupjin for Ruconest in South Korea

27-03-2012

Dutch biotech firm Pharming Group (NYSE Euronext: PHARM) has entered into an agreement with Seoul-based…

Asia-PacificBiotechnologyHyupjin CorpLicensingPharmingRare diseasesRhucinRuconest

EMA strengthens policies on handling of conflicts of interest

26-03-2012

The European Medicines Agency says that, following its implementation in September 2011, the Management…

BiotechnologyEuropeFinancialPharmaceuticalRegulation

1964 to 1988 of 2301 results

Back to top